文献速递垂体与肾上腺疾病

阻塞性睡眠呼吸暂停患者中血浆甲氧基肾上腺素假阳性结果少于尿液甲氧基肾上腺素

Plasma Metanephrines Yield Fewer False-Positive Results Than Urine Metanephrines in Patients With Obstructive Sleep Apnea.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

研究纳入76例疑似阻塞性睡眠呼吸暂停(OSA)患者,比较晨间血浆游离甲氧基肾上腺素与24小时尿液甲氧基肾上腺素的假阳性率。血浆甲氧基肾上腺素在OSA患者中诊断PPGL假阳性更少。

要点

  • 严重OSA患者尿液假阳性率38.2%(13/34),高于轻中度OSA 12.1%(4/33),P<.01。
  • 严重OSA、肥胖及高血压家族史是疑似OSA患者尿液甲氧基肾上腺素假阳性的阳性预测因素。

核心结论

  • 在OSA患者中,血浆甲氧基肾上腺素诊断PPGL的假阳性结果少于24小时尿液甲氧基肾上腺素。
  • 对疑似OSA、肥胖或有高血压家族史的患者,血浆甲氧基肾上腺素可能是首选一线检测以避免不必要的焦虑或随访。

研究设计与样本

  • 招募因疑似OSA接受多导睡眠监测的患者,采用HPLC-MS/MS测定血浆游离及24小时尿液甲氧基肾上腺素。
  • 76例患者完成多导睡眠监测和生化检测,68例(89.5%)患有OSA,其中19例(27.9%)血浆和/或尿液甲氧基肾上腺素升高。
  • 水平升高者重复检测、腹部影像学检查及随访以诊断或排除PPGL。

主要发现

  • 随访中1例患者确诊膀胱副神经节瘤,其余患者排除PPGL。
  • 严重OSA患者尿液假阳性13/34(38.2%),轻中度OSA 4/33(12.1%),P<.01。
  • 持续气道正压通气治疗后血浆和尿液甲氧基肾上腺素均下降。
  • 多因素分析显示严重OSA、肥胖和高血压家族史是疑似OSA患者尿液甲氧基肾上腺素假阳性的阳性预测因素。

临床怎么用

  • 在OSA患者中,血浆甲氧基肾上腺素诊断PPGL的假阳性结果少于24小时尿液甲氧基肾上腺素。
  • 对疑似OSA、肥胖或有高血压家族史的患者,作者认为血浆甲氧基肾上腺素可能是首选一线检测以避免不必要的焦虑或随访。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Obstructive sleep apnea (OSA) is associated with increased nocturnal sympathetic activity. In OSA patients, elevations in metanephrines may lead to false-positive tests when evaluating for pheochromocytoma or paraganglioma (PPGL). OBJECTIVE: To evaluate whether morning plasma metanephrines would lead to fewer false-positive results than 24-hour urinary metanephrines in OSA patients. METHODS: Patients undergoing polysomnography for suspected OSA were recruited. Plasma free and 24-hour urinary metanephrines were measured by HPLC-MS/MS. Patients with elevated levels had repeat measurements, abdominal imaging, and follow-up to diagnose or exclude a PPGL. RESULTS: Seventy-six patients completed polysomnography and biochemical testing; 68 (89.5%) patients had OSA, of whom 19 (27.9%) had elevated plasma and/or urinary metanephrines. On follow-up, one patient had a bladder paraganglioma, while PPGL was excluded in the remaining patients. OSA patients had more false-positive urinary metanephrines (17 of 67, 25.4%) than plasma metanephrines (2 of 67, 3.0%), P < .01, and this was more common in severe OSA (13 of 34, 38.2%), compared to moderate/mild OSA (4 of 33, 12.1%), P < .01. Both plasma and urinary metanephrines decreased after treatment with continuous positive airway pressure. On multivariable analysis, severe OSA, obesity, and family history of hypertension were positive predictors for false-positive urinary metanephrines in patients with suspected OSA. CONCLUSION: In OSA patients, plasma metanephrines are less likely to yield false-positive results for the diagnosis of PPGL than 24-hour urinary metanephrines. In patients with suspected OSA, obesity, or a family history of hypertension, plasma metanephrines may be the preferred first-line test to avoid unnecessary anxiety or follow-up.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. King TFJ, Mok Y, Dacay LM, et al. Plasma Metanephrines Yield Fewer False-Positive Results Than Urine Metanephrines in Patients With Obstructive Sleep Apnea. J Clin Endocrinol Metab. 2024. PMID: 37721483. doi:10.1210/clinem/dgad553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。